vs
ARKO Corp.（ARKO）与德康医疗（DXCM）财务数据对比。点击上方公司名可切换其他公司
ARKO Corp.的季度营收约是德康医疗的1.4倍（$1.8B vs $1.3B），德康医疗净利率更高（21.2% vs 0.1%，领先21.1%），德康医疗同比增速更快（21.6% vs -9.9%），过去两年德康医疗的营收复合增速更高（12.0% vs -7.0%）
ARKO Corp.是美国知名的便利店与燃油零售运营商，业务覆盖美国多个州，面向消费者销售生鲜食品、饮品、日用必需品等商品，同时提供燃油零售及面向商业合作伙伴的批发配送服务。
德康医疗是美国跨国医疗保健企业，专注于研发、生产及销售糖尿病管理领域的连续血糖监测（CGM）系列系统。其全球总部及研发中心位于美国加利福尼亚州圣地亚哥，生产基地分布于美国亚利桑那州梅萨、马来西亚峇都交湾及爱尔兰戈尔韦郡阿斯里。
ARKO vs DXCM — 直观对比
营收规模更大
ARKO
是对方的1.4倍
$1.3B
营收增速更快
DXCM
高出31.5%
-9.9%
净利率更高
DXCM
高出21.1%
0.1%
两年增速更快
DXCM
近两年复合增速
-7.0%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.8B | $1.3B |
| 净利润 | $1.9M | $267.3M |
| 毛利率 | — | 62.9% |
| 营业利润率 | 1.2% | 25.6% |
| 净利率 | 0.1% | 21.2% |
| 营收同比 | -9.9% | 21.6% |
| 净利润同比 | 180.9% | 153.6% |
| 每股收益（稀释后） | $0.01 | $0.67 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARKODXCM
| Q1 26 | — | $1.3B | ||
| Q4 25 | $1.8B | $1.3B | ||
| Q3 25 | $2.0B | $1.2B | ||
| Q2 25 | $2.0B | $1.2B | ||
| Q1 25 | $1.8B | $1.0B | ||
| Q4 24 | $2.0B | $1.1B | ||
| Q3 24 | $2.3B | $994.2M | ||
| Q2 24 | $2.4B | $1.0B |
净利润ARKODXCM
| Q1 26 | — | $267.3M | ||
| Q4 25 | $1.9M | $267.3M | ||
| Q3 25 | $13.5M | $283.8M | ||
| Q2 25 | $20.1M | $179.8M | ||
| Q1 25 | $-12.7M | $105.4M | ||
| Q4 24 | $-2.3M | $151.7M | ||
| Q3 24 | $9.7M | $134.6M | ||
| Q2 24 | $14.1M | $143.5M |
毛利率ARKODXCM
| Q1 26 | — | 62.9% | ||
| Q4 25 | — | 62.9% | ||
| Q3 25 | — | 60.5% | ||
| Q2 25 | — | 59.5% | ||
| Q1 25 | — | 56.9% | ||
| Q4 24 | — | 58.9% | ||
| Q3 24 | — | 59.7% | ||
| Q2 24 | — | 62.4% |
营业利润率ARKODXCM
| Q1 26 | — | 25.6% | ||
| Q4 25 | 1.2% | 25.6% | ||
| Q3 25 | 1.8% | 20.1% | ||
| Q2 25 | 2.8% | 18.4% | ||
| Q1 25 | -0.6% | 12.9% | ||
| Q4 24 | 0.7% | 17.0% | ||
| Q3 24 | 1.8% | 15.3% | ||
| Q2 24 | 1.8% | 15.7% |
净利率ARKODXCM
| Q1 26 | — | 21.2% | ||
| Q4 25 | 0.1% | 21.2% | ||
| Q3 25 | 0.7% | 23.5% | ||
| Q2 25 | 1.0% | 15.5% | ||
| Q1 25 | -0.7% | 10.2% | ||
| Q4 24 | -0.1% | 13.6% | ||
| Q3 24 | 0.4% | 13.5% | ||
| Q2 24 | 0.6% | 14.3% |
每股收益（稀释后）ARKODXCM
| Q1 26 | — | $0.67 | ||
| Q4 25 | $0.01 | $0.67 | ||
| Q3 25 | $0.10 | $0.70 | ||
| Q2 25 | $0.16 | $0.45 | ||
| Q1 25 | $-0.12 | $0.27 | ||
| Q4 24 | $-0.03 | $0.37 | ||
| Q3 24 | $0.07 | $0.34 | ||
| Q2 24 | $0.11 | $0.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $311.5M | $917.7M |
| 总债务越低越好 | $912.1M | — |
| 股东权益账面价值 | $267.2M | $2.7B |
| 总资产 | $3.5B | $6.3B |
| 负债/权益比越低杠杆越低 | 3.41× | — |
8季度趋势，按日历期对齐
现金及短期投资ARKODXCM
| Q1 26 | — | $917.7M | ||
| Q4 25 | $311.5M | $917.7M | ||
| Q3 25 | $313.2M | $1.8B | ||
| Q2 25 | $299.7M | $1.2B | ||
| Q1 25 | $271.1M | $904.9M | ||
| Q4 24 | $267.1M | $606.1M | ||
| Q3 24 | $296.8M | $621.2M | ||
| Q2 24 | $236.5M | $939.2M |
总债务ARKODXCM
| Q1 26 | — | — | ||
| Q4 25 | $912.1M | — | ||
| Q3 25 | $911.6M | — | ||
| Q2 25 | $916.4M | — | ||
| Q1 25 | $880.1M | — | ||
| Q4 24 | $881.0M | — | ||
| Q3 24 | $884.7M | — | ||
| Q2 24 | $889.9M | — |
股东权益ARKODXCM
| Q1 26 | — | $2.7B | ||
| Q4 25 | $267.2M | $2.7B | ||
| Q3 25 | $273.1M | $2.7B | ||
| Q2 25 | $264.8M | $2.6B | ||
| Q1 25 | $255.2M | $2.3B | ||
| Q4 24 | $276.9M | $2.1B | ||
| Q3 24 | $280.0M | $2.0B | ||
| Q2 24 | $273.1M | $2.4B |
总资产ARKODXCM
| Q1 26 | — | $6.3B | ||
| Q4 25 | $3.5B | $6.3B | ||
| Q3 25 | $3.6B | $7.5B | ||
| Q2 25 | $3.6B | $7.3B | ||
| Q1 25 | $3.6B | $6.8B | ||
| Q4 24 | $3.6B | $6.5B | ||
| Q3 24 | $3.7B | $6.4B | ||
| Q2 24 | $3.7B | $6.8B |
负债/权益比ARKODXCM
| Q1 26 | — | — | ||
| Q4 25 | 3.41× | — | ||
| Q3 25 | 3.34× | — | ||
| Q2 25 | 3.46× | — | ||
| Q1 25 | 3.45× | — | ||
| Q4 24 | 3.18× | — | ||
| Q3 24 | 3.16× | — | ||
| Q2 24 | 3.26× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $44.6M | — |
| 自由现金流经营现金流 - 资本支出 | $14.9M | — |
| 自由现金流率自由现金流/营收 | 0.8% | — |
| 资本支出强度资本支出/营收 | 1.7% | — |
| 现金转化率经营现金流/净利润 | 23.98× | — |
| 过去12个月自由现金流最近4个季度 | $65.3M | — |
8季度趋势，按日历期对齐
经营现金流ARKODXCM
| Q1 26 | — | — | ||
| Q4 25 | $44.6M | $294.0M | ||
| Q3 25 | $49.4M | $659.9M | ||
| Q2 25 | $55.2M | $303.0M | ||
| Q1 25 | $43.4M | $183.8M | ||
| Q4 24 | $22.7M | $301.4M | ||
| Q3 24 | $109.2M | $199.5M | ||
| Q2 24 | $77.2M | $279.4M |
自由现金流ARKODXCM
| Q1 26 | — | — | ||
| Q4 25 | $14.9M | $192.1M | ||
| Q3 25 | $24.5M | $579.4M | ||
| Q2 25 | $9.8M | $208.9M | ||
| Q1 25 | $16.0M | $96.8M | ||
| Q4 24 | $-13.4M | $176.8M | ||
| Q3 24 | $79.9M | $88.3M | ||
| Q2 24 | $57.9M | $213.3M |
自由现金流率ARKODXCM
| Q1 26 | — | — | ||
| Q4 25 | 0.8% | 15.3% | ||
| Q3 25 | 1.2% | 47.9% | ||
| Q2 25 | 0.5% | 18.1% | ||
| Q1 25 | 0.9% | 9.3% | ||
| Q4 24 | -0.7% | 15.9% | ||
| Q3 24 | 3.5% | 8.9% | ||
| Q2 24 | 2.4% | 21.2% |
资本支出强度ARKODXCM
| Q1 26 | — | — | ||
| Q4 25 | 1.7% | 8.1% | ||
| Q3 25 | 1.2% | 6.7% | ||
| Q2 25 | 2.3% | 8.1% | ||
| Q1 25 | 1.5% | 8.4% | ||
| Q4 24 | 1.8% | 11.2% | ||
| Q3 24 | 1.3% | 11.2% | ||
| Q2 24 | 0.8% | 6.6% |
现金转化率ARKODXCM
| Q1 26 | — | — | ||
| Q4 25 | 23.98× | 1.10× | ||
| Q3 25 | 3.67× | 2.33× | ||
| Q2 25 | 2.75× | 1.69× | ||
| Q1 25 | — | 1.74× | ||
| Q4 24 | — | 1.99× | ||
| Q3 24 | 11.28× | 1.48× | ||
| Q2 24 | 5.49× | 1.95× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ARKO
| Fuel Products | $1.4B | 79% |
| Merchandise Products | $338.1M | 19% |
| Other Product | $33.6M | 2% |
DXCM
暂无分部数据
